Literature DB >> 22740930

Association of the DNMT3A -448A>G polymorphism with genetic susceptibility to colorectal cancer.

Zhujiang Zhao1, Can Li, Yunwei Song, Qunying Wu, Fengchang Qiao, Hong Fan.   

Abstract

The DNA methyltransferase 3A (DNMT3A) -448A>G polymorphism is a novel functional single nucleotide polymorphism (SNP) that contributes to the genetic susceptibility to gastric cancer. In this study, we aimed to assess the genotype frequencies of DNMT3A -448A>G in colorectal cancer (CRC) patients and healthy control subjects, and to explore the association of the DNMT3A functional SNP, -448A>G, with genetic susceptibility to CRC. Genomic DNA was extracted from samples of 258 patients with CRC and 280 healthy controls. Polymerase chain reaction-restriction fragment length polymorphism analysis was employed to assess the genotype frequencies of DNMT3A -448A>G in all of the subjects. Stratification analyses were used to study subgroups of subjects by age and gender, and to evaluate the association between the DNMT3A -448A>G polymorphism and the genetic susceptibility to CRC. The allele frequency of -448A among CRC patients and the controls was 26.4 versus 19.8%, respectively. Overall, we found that compared with GG carriers, the DNMT3A -448AA homozygotes had a 3.692-fold increased risk of CRC. Stratification analysis showed a significant difference in this SNP between the CRC patients and the control subjects of different genders. AA homozygotes carried an increased risk in the subgroup of individuals aged ≥50 years in male CRC. Compared with GG homozygotes in females aged ≥50 years, the AG and AA genotypes carried a 0.355-fold decreased risk in this subgroup. These data imply that the DNMT3A SNP -448A>G contributes to genetic susceptibility to CRC. -448A>G may be used as a stratification marker to predict the susceptibility of certain individuals to CRC, particularly in male individuals aged ≥50 years.

Entities:  

Year:  2011        PMID: 22740930      PMCID: PMC3362412          DOI: 10.3892/ol.2011.488

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

1.  Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994.

Authors:  R J Troisi; A N Freedman; S S Devesa
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

Review 2.  Serrated adenoma of the colorectum and the DNA-methylator phenotype.

Authors:  Jeremy R Jass
Journal:  Nat Clin Pract Oncol       Date:  2005-08

3.  The relation of age, race, and gender to the subsite location of colorectal carcinoma.

Authors:  R L Nelson; T Dollear; S Freels; V Persky
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

4.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.

Authors:  K D Robertson; E Uzvolgyi; G Liang; C Talmadge; J Sumegi; F A Gonzales; P A Jones
Journal:  Nucleic Acids Res       Date:  1999-06-01       Impact factor: 16.971

Review 5.  Colorectal carcinoma in black and white race.

Authors:  William F Anderson; Asad Umar; Otis W Brawley
Journal:  Cancer Metastasis Rev       Date:  2003-03       Impact factor: 9.264

6.  A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma.

Authors:  Hong Fan; Dongsheng Liu; Xuemei Qiu; Fengchang Qiao; Qingxiang Wu; Xianwei Su; Feng Zhang; Yunwei Song; Zhujiang Zhao; Wei Xie
Journal:  BMC Med       Date:  2010-02-03       Impact factor: 8.775

7.  Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.

Authors:  Michael S Samuel; Hiromu Suzuki; Michael Buchert; Tracy L Putoczki; Niall C Tebbutt; Therése Lundgren-May; Aliki Christou; Melissa Inglese; Minoru Toyota; Joan K Heath; Robyn L Ward; Paul M Waring; Matthias Ernst
Journal:  Gastroenterology       Date:  2009-05-18       Impact factor: 22.682

8.  A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.

Authors:  Yong Shin; Il-Jin Kim; Hio Chung Kang; Jae-Hyun Park; Hye-Won Park; Sang-Geun Jang; Min Ro Lee; Seung-Yong Jeong; Hee Jin Chang; Ja-Lok Ku; Jae-Gahb Park
Journal:  Carcinogenesis       Date:  2004-07-01       Impact factor: 4.944

9.  DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese.

Authors:  Hong Fan; Dong-Sheng Liu; Shu-Hong Zhang; Jia-Bo Hu; Feng Zhang; Zhu-Jiang Zhao
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

10.  5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.

Authors:  Regine Schneider-Stock; Mona Diab-Assef; Astrid Rohrbeck; Charlotte Foltzer-Jourdainne; Carsten Boltze; Roland Hartig; Peter Schönfeld; Albert Roessner; Hala Gali-Muhtasib
Journal:  J Pharmacol Exp Ther       Date:  2004-11-16       Impact factor: 4.030

View more
  8 in total

1.  Association of DNA methyltransferase polymorphisms with susceptibility to primary gouty arthritis.

Authors:  Xiaowu Zhong; Yuanhong Peng; Chengjiao Yao; Yufeng Qing; Qibin Yang; Xiaolan Guo; Wenguang Xie; Mingcai Zhao; Xiaoming Cai; Jing-Guo Zhou
Journal:  Biomed Rep       Date:  2016-08-26

2.  DNA methyltransferase 3a rs1550117 genetic polymorphism predicts poor survival in gastric cancer patients.

Authors:  Chuan Wang; Zhifang Jia; Hongxi Ma; Donghui Cao; Xing Wu; Simin Wen; Lili You; Xueyuan Cao; Jing Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  DNMT3A -448A>G polymorphism and the risk for hepatocellular carcinoma.

Authors:  Chengcheng Zhao; Feng Yan; Huazhang Wu; Fengchang Qiao; Xuemei Qiu; Hong Fan
Journal:  Biomed Rep       Date:  2013-05-30

4.  Meta-analysis Reveals No Association of DNMT3B -149 C>T Gene Polymorphism With Overall Cancer Risk.

Authors:  Raju Kumar Mandal; Shafiul Haque; Mohd Wahid; Arshad Jawed; Naseem Akhter; Md Ekhlaque Ahmed Khan; Aditya Kumar Panda; Mohammed Yahya Areeshi; Sajad Ahmad Dar
Journal:  Curr Genomics       Date:  2016-12       Impact factor: 2.236

5.  The rs1550117 A>G variant in DNMT3A gene promoter significantly increases non-small cell lung cancer susceptibility in a Han Chinese population.

Authors:  Jingdong Wang; Chade Li; Fengting Wan; Zhou Li; Jingli Zhang; Jiankun Zhang; Xianhong Feng; Liang Tang; Bifeng Chen
Journal:  Oncotarget       Date:  2017-04-04

6.  DNMT1, DNMT3A and DNMT3B gene variants in relation to ovarian cancer risk in the Polish population.

Authors:  Adrianna Mostowska; Stefan Sajdak; Piotr Pawlik; Margarita Lianeri; Paweł P Jagodzinski
Journal:  Mol Biol Rep       Date:  2013-05-12       Impact factor: 2.316

7.  A novel functional TagSNP Rs7560488 in the DNMT3A1 promoter is associated with susceptibility to gastric cancer by modulating promoter activity.

Authors:  Huazhang Wu; Kun Zhang; Pihai Gong; Fengchang Qiao; Ling Wang; He Cui; Xinyuan Sui; Jifan Gao; Hong Fan
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

8.  Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.

Authors:  Xiao-Qing Yuan; Dao-Yu Zhang; Han Yan; Yong-Long Yang; Ke-Wei Zhu; Yan-Hong Chen; Xi Li; Ji-Ye Yin; Xiao-Lin Li; Hui Zeng; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.